Your Joint OptionsFind my next step

Medically reviewed by Charles A. DeCook, MD ·

← All options
Specialist review

Hip resurfacing

A different implant operation. Still surgery.

01

What could it help with?

Hip resurfacing caps the femoral head and replaces the socket surface. It is a surgical alternative for a narrow group after assessment of bone quality, anatomy, and implant risks. [1][2]

02

Who might it suit?

For: A narrow group selected by a specialist after films and risk review.

Not for: Every hip, poor bone quality, or people with device-specific contraindications.

03

Limits and important cautions

Metal-related reactions and future revision are important considerations. Device approval is not evidence that resurfacing is better than total hip replacement for everyone.

What happens, how long, and what could it cost?
What happens
Specialist evaluation, imaging review, shared decision-making, and preparation for an operation.
When might I notice a change?
Recovery and rehabilitation take time; discuss milestones rather than a guaranteed recovery date.
How long might benefit last?
Long-term outcome and the chance of further surgery depend on the operation, implant, and patient.
Repeat treatment
Ask about routine follow-up and circumstances that could require revision or another operation.
Activity and recovery
Obtain individualized instructions for walking aids, wound care, work, driving, and rehabilitation.
Ask for a complete estimate
Surgeon, implant, hospital or facility, anesthesia, rehabilitation, and follow-up.

Use this as a consultation guide. A timeline is not a guarantee; the evidence and FDA sections below remain part of the decision.

Compare expectations side by side ↗

THE EVIDENCE IN CONTEXT

Highly selective implant procedure

Read the 2 selected references
  1. Za et al.: hip resurfacing versus total hip replacement ↗Systematic review of randomized trials · 2024

    Eight trials, 844 patients. No statistically significant difference in functional scores or revision rates; fewer dislocations with resurfacing. Selected trial populations and implants limit generalization; absence of a significant difference is not proof of equivalence.

  2. FDA: metal-on-metal hip implants for patients ↗Regulatory safety guidance · Current guidance

    Explains metal-related risks, device-specific follow-up, and revision concerns. Safety guidance does not establish superiority over total hip replacement.

Editorial synthesis · reviewed September 19, 2026. These are selected decision-relevant references, not an exhaustive systematic review or a new formal evidence grade. FDA status and coverage are assessed separately.

FDA status

Product-specific implant approval

Specific systems have FDA approvals and selection requirements. Approval does not make everyone a candidate.

Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.
What do professional guidelines say?

ACR: No recommendation for this specific use in the ACR osteoarthritis guideline.

Will Medicare cover it?

Coverage requires medical necessity and plan review.

How we interpret changing evidence